FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1324211000001105: Salicylamide 5% / Benzocaine 2% gel 50 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21684901000001118 Salicylamide 5% / Benzocaine 2% gel 50 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21685001000001118 Salicylamide 5% / Benzocaine 2% gel 50 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylamide 5% / Benzocaine 2% gel 50 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Is pack of Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has active ingredient Salicylamide false Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has active ingredient Benzocaine false Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has VMP Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has specific active ingredient Salicylamide true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has specific active ingredient Benzocaine true Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) 50 gram Is a True Salicylamide 5% / Benzocaine 2% gel 50 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start